Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP).

Full DD Report for ZIOP

You must become a subscriber to view this report.


Recent News from (NASDAQ: ZIOP)

Gene therapy players under pressure
The Nasdaq's selloff notwithstanding, most gene therapy stocks are in the red. This morning, Sangamo Therapeutics ( SGMO -21.1% ) reported data on SB-913 that disappointed investors. More news on: Sangamo Therapeutics, Inc., AVROBIO, MeiraGTx Holdings plc, Healthcare stocks news, Stocks ...
Source: SeekingAlpha
Date: September, 05 2018 10:58
CORRECTING and REPLACING -- Ziopharm Oncology Announces Scott Braunstein, M.D., Operating Partner at Aisling Capital, Nominated to Board of Directors
BOSTON, Sept. 04, 2018 (GLOBE NEWSWIRE) -- In a release issued earlier today by  Ziopharm Oncology , Inc. (Nasdaq:ZIOP), please note the Company's upcoming annual meeting of stockholders is being held Sept. 18 rather than Sept. 8 as originally issued. The corrected release follows...
Source: GlobeNewswire
Date: September, 04 2018 09:15
Ziopharm Oncology Announces Scott Braunstein, M.D., Operating Partner at Aisling Capital, Nominated to Board of Directors
BOSTON, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP) today announced that its Board of Directors has nominated Scott Braunstein, M.D., an Operating Partner at Aisling Capital, a leading healthcare investment firm, for election to the Board of Directors at the...
Source: GlobeNewswire
Date: September, 04 2018 07:30
Ziopharm Oncology Is An Attractive Buy For 2018
Headquartered in Boston, Massachusetts, Ziopharm Oncology ( ZIOP ) is focused on deploying next-generation immune-oncology gene and cell therapies to target blood cancers and solid tumors. The company is currently working on two platforms that are targeting the most important challenges in t...
Source: SeekingAlpha
Date: September, 01 2018 13:22

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-142.882.83883.072.8051,062,093
2018-12-132.982.942.982.811,306,675
2018-12-123.222.983.292.931,696,694
2018-12-113.133.183.263.061,795,915
2018-12-103.113.053.243.02944,690

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-14172,143290,31459.2955Short
2018-12-13181,574451,77840.1910Short
2018-12-12290,747482,22560.2928Short
2018-12-11397,438516,05577.0147Short
2018-12-10141,100228,83161.6612Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ZIOP.


About ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP)

Logo for ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP)

Not available

 

Contact Information

 

 

Current Management

  • Jonathan Lewis / CEO

Current Share Structure

  • Market Cap: $97,662,634 - 05/18/2018
  • Issue and Outstanding: 21,848,464 - 03/12/2009

 


Recent Filings from (NASDAQ: ZIOP)

Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: September, 04 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: August, 31 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: August, 29 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 08 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: August, 08 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: August, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 18 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018

 

 


Daily Technical Chart for (NASDAQ: ZIOP)

Daily Technical Chart for (NASDAQ: ZIOP)


Stay tuned for daily updates and more on (NASDAQ: ZIOP)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ZIOP)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ZIOP is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ZIOP and does not buy, sell, or trade any shares of ZIOP. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/